Clinical Trials Directory

Trials / Unknown

UnknownNCT03351777

Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Realm Therapeutics, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether PR022 Topical Gels are safe and effective treatments for mild-to-moderate atopic dermatitis (AD).

Conditions

Interventions

TypeNameDescription
DRUGPR022Topical Gel

Timeline

Start date
2017-12-04
Primary completion
2018-04-01
Completion
2018-07-01
First posted
2017-11-24
Last updated
2017-12-21

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03351777. Inclusion in this directory is not an endorsement.

Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis (NCT03351777) · Clinical Trials Directory